Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Afluria Quad |
| Active Ingredients: | Influenza virus A/Hong Kong/2671/2019 (H3N2)-like virus 15mcg Influenza virus A/Victoria/2570/2019 (H1N1) pdm09-like virus 15mcg Influenza virus B/Phuket/3073/2013 - like strain 15mcg Influenza virus B/Washington/02/2019-like (B/Victoria lineage) virus 15mcg |
| Dosage Form: | Suspension for injection |
| New Zealand Sponsor: | Seqirus (NZ) Limited |
| Manufacturers: | Seqirus Pty Limited, Melbourne, Australia CSL Behring LLC, Illinois, United States of America CSL Behring GmbH, Marburg, Germany |
| Product: | Afluria Quad Junior |
| Active Ingredients: | Influenza virus A/Hong Kong/2671/2019 (H3N2)-like virus 7.5mcg Influenza virus A/Victoria/2570/2019 (H1N1) pdm09-like virus 7.5mcg Influenza virus B/Phuket/3073/2013 - like strain 7.5mcg Influenza virus B/Washington/02/2019-like (B/Victoria lineage) virus 7.5mcg |
| Dosage Form: | Suspension for injection |
| New Zealand Sponsor: | Seqirus (NZ) Limited |
| Manufacturer: | Seqirus Pty Limited, Melbourne, Australia |
Dated this 10th day of November 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).